Streetbeat News

Stock Prices

MPC

Over the past 10 years, Marathon Petroleum (NYSE:MPC) has outperformed the market with an annualized return of 16.23%, turning a $1000 investment into $4,628.22 today. The company's market capitalization stands at $72.49 billion.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:06 pm

PTC

PTC (NASDAQ:PTC) has delivered an average annual return of 15.29% over the past 5 years, outperforming the market by 2.28% on an annualized basis. With a current market capitalization of $22.75 billion, a $1000 investment in PTC 5 years ago would now be worth $2,077.34. This performance highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:06 pm

ERIC

FIVG

IDGT

NOK

T

Ericsson (NASDAQ:ERIC) is laying off 1,200 employees in Sweden, 8.6% of its Swedish workforce, due to decreased demand and a cautious approach from mobile service providers. This is part of a broader cost-cutting strategy amid challenges in the European telecom equipment sector. The company had previously announced a pessimistic outlook for 2024 but expects a surge in the latter half due to a $14 billion agreement with AT&T Inc (NYSE:T). Ericsson's stock has gained 8% in the last six months, and exposure to Ericsson can be gained through IShares U.S. Digital Infrastructure And Real Estate ETF (NYSE:IDGT) and Defiance Next Gen Connectivity ETF (NYSE:FIVG).

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 4:06 pm

ABBV

CERE

LABP

AbbVie Inc (NYSE:ABBV) has agreed to acquire Landos Biopharma Inc (NASDAQ:LABP) for $20.42 per share, totaling approximately $137.5 million, plus contingent value rights potentially adding $75 million. The acquisition focuses on Landos' lead asset, NX-13, aimed at treating ulcerative colitis and Crohn's disease. Additionally, AbbVie recently acquired ImmunoGen, adding Elahere to its portfolio, and agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) to expand its neuroscience presence.

Portfolio Pulse from Vandana Singh

March 25, 2024 | 4:06 pm

SGMT

Sagimet Biosciences shares surged following the announcement of its FY23 financial results. Additionally, Leerink Partners initiated coverage on Sagimet Biosciences with an Outperform rating and set a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:06 pm

BTM

Bitcoin Depot shares dropped following a report of disappointing Q4 revenue results and lower than expected Q1 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:06 pm

DWAC

PHUN

SPY

Former President Trump has been granted the option to pay a reduced bond while appealing a $454 million fine imposed by New York. This development could have implications for assets related to Trump, including DWAC and PHUN, as well as broader market indicators like SPY.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:06 pm

TTWO

Financial analysis of Take-Two Interactive (NASDAQ:TTWO) options trading reveals a bearish sentiment among traders, with 55% showing bearish tendencies and 44% bullish. The analysis highlighted significant trades within a price window of $130.0 to $175.0. The current market price of TTWO is $150.29, with a neutral RSI indicator. The company, known for major video game titles and owning labels like Rockstar Games and Zynga, is a significant player in the video game industry.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:06 pm

MA

Deep-pocketed investors have shown a bearish sentiment towards Mastercard (NYSE:MA), with unusual options activity detected. A significant portion of the activity involves puts, indicating expectations of a price decline. Despite this, Mastercard remains a strong player in the payment processing industry, with a neutral RSI indicator and upcoming earnings expected in 31 days. Analysts from Wells Fargo and Jefferies maintain positive ratings with target prices above the current stock price.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:06 pm

VIVK

Vivakor's shares are trading lower following the announcement of a definitive Membership Interest Purchase Agreement to acquire Endeavor Entities.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:05 pm